Showing results (811-820 of 929) with videos related to

Sort By:
Pageof 93
BMJ Open|April 3, 2012
Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressantsVictor M Castro, Patience J Gallagher, Caitlin C Clements, et al.
International Journal of Molecular Sciences|October 27, 2022
Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated SignalingStephen M Stahl, Sara De Martin, Andrea Mattarei, et al.
The New England Journal of Medicine|March 24, 2006
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depressionA John Rush, Madhukar H Trivedi, Stephen R Wisniewski, et al.
The American Journal of Psychiatry|September 2, 2006
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D reportAndrew A Nierenberg, Maurizio Fava, Madhukar H Trivedi, et al.
BMJ (Clinical Research Ed.)|January 31, 2013
QT interval and antidepressant use: a cross sectional study of electronic health recordsVictor M Castro, Caitlin C Clements, Shawn N Murphy, et al.
JAMA Psychiatry|June 6, 2014
An electronic health records study of long-term weight gain following antidepressant useSarah R Blumenthal, Victor M Castro, Caitlin C Clements, et al.
The Journal of Clinical Psychiatry|August 7, 2008
Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D reportWilliam S Gilmer, Jackie K Gollan, Stephen R Wisniewski, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|September 14, 2020
Dorsolateral Prefrontal Cortex and Subcallosal Cingulate Connectivity Show Preferential Antidepressant Response in Major Depressive DisorderCherise R Chin Fatt, Crystal Cooper, Manish K Jha, et al.
Nature Human Behaviour|September 25, 2019
Brain regulation of emotional conflict predicts antidepressant treatment response for depressionGregory A Fonzo, Amit Etkin, Yu Zhang, et al.
The Australian and New Zealand Journal of Psychiatry|February 20, 2016
Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalationCristina Cusin, Dawn Flosnik Ionescu, Kara Jean Pavone, et al.
Pageof 93